Product Description: Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Iparomlimab. INN number: 11840. IMGT.